回肠切除患者的高草酸尿症：饮食中草酸盐吸收异常。 - Suppr

Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption.

作者信息

Earnest D L, Johnson G, Williams H E, Admirand W H

出版信息

Gastroenterology. 1974 Jun;66(6):1114-22.

PMID:4829118

Abstract

摘要

相似文献

Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption.

Gastroenterology. 1974 Jun;66(6):1114-22.

Hyperoxaluria and calcium oxalate nephrolithiasis after jejunoileal bypass.

Am J Clin Nutr. 1977 Jan;30(1):64-71. doi: 10.1093/ajcn/30.1.64.

Low-oxalate, low-fat dietary regimen in hyperoxaluria following jejunoileal bypass.

Acta Chir Scand. 1983;149(1):89-91.

A physicochemical basis for treatment of enteric hyperoxaluria.

Trans Assoc Am Physicians. 1975;88:224-34.

Letter: Hyperoxaluria with ileal dysfunction.

N Engl J Med. 1974 Jan 10;290(2):107-8. doi: 10.1056/NEJM197401102900216.

Enteric hyperoxaluria.

Adv Intern Med. 1979;24:407-27.

[Hyperoxaluria and renal calculi].

Arch Esp Urol. 1996 Sep;49(7):707-26.

Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.

Arch Ital Urol Androl. 2002 Jun;74(2):61-4.

Mechanism for hyperoxaluria in patients with ileal dysfunction.

N Engl J Med. 1973 Jul 26;289(4):172-6. doi: 10.1056/NEJM197307262890402.

The management of patients with enteric hyperoxaluria.

Urolithiasis. 2016 Feb;44(1):33-43. doi: 10.1007/s00240-015-0846-5. Epub 2015 Dec 8.

引用本文的文献

Comprehensive Mendelian randomization analysis and experimental investigation identifies the causal relationship between immunity and kidney stone disease.

Urolithiasis. 2025 Jun 11;53(1):110. doi: 10.1007/s00240-025-01782-5.

Metabolic Profile of Calcium Oxalate Stone Patients with Enteric Hyperoxaluria and Impact of Dietary Intervention.

Nutrients. 2024 Aug 13;16(16):2688. doi: 10.3390/nu16162688.

Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.

Nutrients. 2024 Jan 16;16(2):264. doi: 10.3390/nu16020264.

What treatments reduce kidney stone risk in patients with bowel disease?

Urolithiasis. 2022 Oct;50(5):557-565. doi: 10.1007/s00240-022-01352-z. Epub 2022 Aug 17.

Dietary Management of Chronic Kidney Disease and Secondary Hyperoxaluria in Patients with Short Bowel Syndrome and Type 3 Intestinal Failure.

Nutrients. 2022 Apr 14;14(8):1646. doi: 10.3390/nu14081646.

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria.

Mol Syst Biol. 2022 Mar;18(3):e10539. doi: 10.15252/msb.202110539.

Oxalate nephropathy: a review.

Clin Kidney J. 2021 Aug 12;15(2):194-204. doi: 10.1093/ckj/sfab145. eCollection 2022 Feb.

Nutrition and Kidney Stone Disease.

Nutrients. 2021 Jun 3;13(6):1917. doi: 10.3390/nu13061917.

Effect of Fat-Soluble Vitamins A, D, E and K on Vitamin Status and Metabolic Profile in Patients with Fat Malabsorption with and without Urolithiasis.

Nutrients. 2020 Oct 12;12(10):3110. doi: 10.3390/nu12103110.

A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.

Transplant Direct. 2017 Nov 8;3(12):e331. doi: 10.1097/TXD.0000000000000748. eCollection 2017 Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献